Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis

Significance Statement Because of multiple comorbidities and demographic characteristics, patients on dialysis are at high risk for COVID-19–related morbidity and mortality. However, such patients were not included in SARS-CoV-2 vaccine trials. To study the real-world effectiveness and immunogenicity of two mRNA SARS-CoV-2 vaccines (BNT162b2 and mRNA-1273) in a large, representative population of in-center hemodialysis patients in the United...